• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Alignment Healthcare Inc.

    5/11/26 4:36:01 PM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001222028
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    ALIGNMENT HEALTHCARE INC
    SEC File Number
    001-40295
    Address of Issuer
    1100 W. Town and Country Road
    Orange
    CALIFORNIA
    92868
    Phone
    8443102247
    Name of Person for Whose Account the Securities are To Be Sold
    JEK TRUST U/A DTD 02/08/2021
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director
    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    59600010686280.0020673382305/11/2026
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common05/09/2014Shares Issued Pre-IPO in exchange for Partnership UnitsIssuerCheckbox not checked59600005/09/2014N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common04/13/2026822991711654.60
    10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common04/10/20262157014450278.32
    10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common04/07/20262500005252900.00
    10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common03/23/20261180002062435.60
    JOHN E KAO
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common03/18/2026730461303140.64
    JOHN E KAO
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common03/12/202648899853125.50
    10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021
    1100 W. Town and Country Road
    Orange � CA � 92868
    Common03/10/20261800003273558.00

    144: Remarks and Signature

    Remarks
    The securities to be sold were Shares Issued Pre-IPO in exchange for Partnership Units during the period of 05/09/2014 through 09/07/2025.
    Date of Notice
    05/11/2026
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    11/21/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ John Kao

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    4/17/2026$24.00Outperform
    Wolfe Research
    11/24/2025$20.00Neutral → Overweight
    Analyst
    10/14/2025$21.00Buy
    Goldman
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    More analyst ratings

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report

    ORANGE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today issued its 2025 Impact Report, detailing how its care model helps members stay healthier with earlier care and reduces the likelihood of emergencies and more serious health events. The report outlines Alignment's approach to coordinated, proactive care, resulting in fewer emergency room visits, hospital stays and post-acute care compared to Medicare fee-for-service benchmarks. As Alignment marks its fifth year as a publicly held company, the report also reflects a refreshed impact strategy centered on improving member health, advancing collaboration and growing responsibly. "From the start,

    6/2/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

    ORANGE, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami, Florida, on Tuesday, June 9, at 10:40 a.m. EDT. A webcast and replay of the presentation will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its

    5/18/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality

    ORANGE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). Out of 613 eligible contracts, only 1.6% achieved recognition, highlighting the significance of this award. The recognition marks the seventh time Alignment has received this award, reinforcing its dedication to providing the best care for seniors. The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use. "We are incredibly honored that Alignment Healt

    5/14/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President - MSO Kent Mark D. bought $197,627 worth of shares (14,848 units at $13.31) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:58:05 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    5/15/26 4:05:34 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    5/15/26 7:48:19 AM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Alignment Healthcare Inc.

    DEFA14A - Alignment Healthcare, Inc. (0001832466) (Filer)

    5/12/26 4:34:29 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Alignment Healthcare with a new price target

    Wolfe Research initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $24.00

    4/17/26 8:10:24 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by Analyst with a new price target

    Analyst upgraded Alignment Healthcare from Neutral to Overweight and set a new price target of $20.00

    11/24/25 8:06:33 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President - MSO Kent Mark D. bought $197,627 worth of shares (14,848 units at $13.31) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:58:05 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Hochradel Shane J.

    3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    6/2/26 6:52:15 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Kent Mark D.

    3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    5/20/26 4:05:46 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion

    Delivers $1.24 billion in total revenue, representing 33.3% growth year-over-yearGrows Medicare Advantage membership 30.9% year-over-year to approximately 284,800 membersRaises the midpoint of all guidance metrics: membership, revenue, adjusted gross profit and adjusted EBITDA ORANGE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its first quarter ended March 31, 2026. "Our first-quarter performance demonstrates that Alignment continues to grow with discipline," said John Kao, founder and CEO. "We expanded our profitability by executing across sales, clinical operations and cost management, even as the Medicare A

    4/30/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026

    ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/53zw9jkh A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and w

    4/9/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics

    Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises health plan membership guidance by 2,000 at the midpoint and introduces 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 millionEarns recognition on the 2026 Fortune World's Most Admired Companies™ list, underscoring the company's innovative approach to senior health care ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC),

    2/26/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Healthcare Set to Join S&P SmallCap 600

    NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14. S&P SmallCap 600 constituent Allegiant Travel Co. (NASD: ALGT) is acquiring Sun Country Airlines Holdings in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorMay 14, 2026S&P SmallCap 600AdditionAlignment HealthcareALHCHealth CareMay 14, 2026S&P SmallCap 600DeletionSun Country Airli

    5/11/26 6:21:00 PM ET
    $ALGT
    $ALHC
    $SNCY
    Air Freight/Delivery Services
    Consumer Discretionary
    Medical Specialities
    Health Care

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care